Stay updated on Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.

Latest updates to the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page
- Check2 days agoChange DetectedAdministrative updates were logged: new revision notes (v3.3.4) dated 2026-01-10 and 2026-01-13, and deletions of earlier revisions (v3.3.3) dated 2026-01-03 and 2026-01-06. These changes do not modify the trial data, eligibility criteria, or outcomes presented on the page.SummaryDifference0.1%

- Check9 days agoChange DetectedNew update dates 2026-01-06 and 2026-01-03 appear in the study record, while the earlier dates 2025-12-30 and 2025-12-27 were removed. This change reflects updates to the record's revision history rather than any modification to the study content.SummaryDifference0.1%

- Check16 days agoChange DetectedThe study record history shows additions of update dates 2025-12-30 and 2025-12-27 and deletions of 2025-12-20 and 2025-12-23. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check23 days agoChange DetectedAdded a new Locations section listing participating sites across Arizona, California, Colorado, Florida, Kansas, Maryland, Minnesota, Missouri, Nebraska, New York, North Carolina, Pennsylvania, Texas, and Utah; updated the page revision to v3.3.3.SummaryDifference1%

- Check30 days agoChange DetectedAdded study record update dates 2025-12-16 and 2025-12-13, and removed dates 2025-12-09 and 2025-12-06 from the Study Record Dates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedNew update dates were added (2025-12-09, 2026-01-06, 2025-12-06, 2025-12) and older timestamps removed, with no substantive changes to the study details.SummaryDifference0.2%

Stay in the know with updates to Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.